Onsite drug testing
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
U. S. SECRET SERVICE
Contract Value
Not provided
Codes & Classification
Solicitation Number
70US0926Q70092860
NAICS
621999 - All Other Miscellaneous Ambulatory Health Care Services
Classification Code
Q999
Additional Details
The U.S. Secret Service, operating under the Department of Homeland Security, has issued a solicitation for onsite drug testing services, as indicated by procurement identifier 70US0926Q70092860. This procurement seeks to secure comprehensive onsite drug testing solutions to support the agency’s operational and personnel requirements at its Washington, District of Columbia location.
The scope of this solicitation encompasses the provision of all necessary labor, materials, equipment, and expertise to conduct drug testing services directly at the designated federal site. The intended outcome is to ensure a safe, secure, and drug-free workplace environment, in alignment with federal mandates and agency-specific policies. Contractors will be expected to deliver reliable, timely, and confidential drug testing services, adhering to all applicable federal, state, and local regulations.
Key requirements include the ability to perform a range of drug testing procedures onsite, manage chain-of-custody protocols, and provide accurate and prompt reporting of results. The solicitation references updated provisions and clauses (as per Amendment 1), which are available in the attached documentation for detailed review. Contractors should be prepared to comply with all specified terms and conditions outlined in these attachments.
This opportunity is classified under NAICS code 621999, “All Other Miscellaneous Ambulatory Health Care Services,” and product service code Q999, indicating a focus on specialized health care services not elsewhere classified. The procurement is set aside for SBA-eligible small businesses, presenting a targeted opportunity for qualified small business contractors with relevant experience in onsite drug testing and health care service delivery.
The place of performance is Washington, DC, and all services must be rendered within the United States. The contracting office is the U.S. Secret Service, with primary and secondary points of contact provided for inquiries: Willie Bethune ([email protected]) and Erik Syfert ([email protected]).
Interested contractors should note the active status of this solicitation, with a response deadline of August 26, 2026. All relevant attachments, including the Q&A and revised provisions/clauses, are available via the official SAM.gov opportunity listing (https://sam.gov/opp/0913e8c4106c45fdb72224549c90d994/view).
This procurement represents a recurring and mission-critical requirement for the U.S. Secret Service, emphasizing the need for dependable, compliant, and discreet onsite drug testing services. Contractors with demonstrated capabilities in this domain, particularly those qualifying under SBA set-aside criteria, are encouraged to review the solicitation documents thoroughly and consider submitting a proposal.
Documents7